These findings indicate that ZIP9 is transcriptionally downregulated not only in HCC patient-derived TAMs but also in human liver cancer tissues, which suggests that ZIP9 may be involved in hepatocarcinogenesis by participating in TAMs differentiation. This evidence concerns the gene SLC39A9 and liver cancer.